Automated identification of leukocyte subsets improves standardization of database-guided expert-supervised diagnostic orientation in acute leukemia: a EuroFlow study

. 2021 Jan ; 34 (1) : 59-69. [epub] 20200930

Jazyk angličtina Země Spojené státy americké Médium print-electronic

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid32999413
Odkazy

PubMed 32999413
PubMed Central PMC7806506
DOI 10.1038/s41379-020-00677-7
PII: S0893-3952(22)00394-5
Knihovny.cz E-zdroje

Precise classification of acute leukemia (AL) is crucial for adequate treatment. EuroFlow has previously designed an AL orientation tube (ALOT) to guide toward the relevant classification panel and final diagnosis. In this study, we designed and validated an algorithm for automated (database-supported) gating and identification (AGI tool) of cell subsets within samples stained with ALOT. A reference database of normal peripheral blood (PB, n = 41) and bone marrow (BM; n = 45) samples analyzed with the ALOT was constructed, and served as a reference for the AGI tool to automatically identify normal cells. Populations not unequivocally identified as normal cells were labeled as checks and were classified by an expert. Additional normal BM (n = 25) and PB (n = 43) and leukemic samples (n = 109), analyzed in parallel by experts and the AGI tool, were used to evaluate the AGI tool. Analysis of normal PB and BM samples showed low percentages of checks (<3% in PB, <10% in BM), with variations between different laboratories. Manual analysis and AGI analysis of normal and leukemic samples showed high levels of correlation between cell numbers (r2 > 0.95 for all cell types in PB and r2 > 0.75 in BM) and resulted in highly concordant classification of leukemic cells by our previously published automated database-guided expert-supervised orientation tool for immunophenotypic diagnosis and classification of acute leukemia (Compass tool). Similar data were obtained using alternative, commercially available tubes, confirming the robustness of the developed tools. The AGI tool represents an innovative step in minimizing human intervention and requirements in expertise, toward a "sample-in and result-out" approach which may result in more objective and reproducible data analysis and diagnostics. The AGI tool may improve quality of immunophenotyping in individual laboratories, since high percentages of checks in normal samples are an alert on the quality of the internal procedures.

Applied Medical Research Center Pamplona Spain

Biomedical Research Networking Centre Consortium of Oncology Instituto de Salud Carlos 3 Madrid Spain

Cytognos SL Salamanca Spain

Department of Hematology University of Schleswig Holstein Campus Kiel Kiel Germany

Department of Immunohematology and Blood Transfusion Leiden The Netherlands

Department of Immunology Laboratory for Medical Immunology Erasmus MC University Medical Center Rotterdam Rotterdam The Netherlands

Department of Medicine University of Salamanca Salamanca Spain

Department of Microbiology and Immunology Medical University of Silesia in Katowice Zabrze Poland

Department of Pediatric Hematology and Oncology Medical University of Silesia in Katowice Zabrze Poland

Department of Pediatric Hematology and Oncology University Hospital Motol Charles University Prague Czechia

FACS Stem Cell Laboratory Kantonsspital Aarau Aarau Switzerland

Hemato Oncology Laboratory Portuguese Institute of Oncology Lisbon Portugal

Institut Necker Enfants Malades Institut National de Recherche Médicale U1151 Laboratory of Onco Hematology Assistance Publique Hôpitaux de Paris Hôpital Necker Enfants Malades Université de Paris Paris France

Institute of Biomedical Research of Salamanca Salamanca Spain

Laboratory of Hematology University Hospital of Saint Etienne Saint Etienne France

Pediatrics Institute IPPMG Faculty of Medicine Federal University of Rio de Janeiro Av Horacio Macedo Predio do CT CEP Rio de Janeiro 21941 914 Brazil

Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands

Systems and Computing Department Rio de Janeiro Brazil

Tettamanti Research Center Pediatric Clinic University of Milano Bicocca Monza MB Italy

Translational and Clinical Research Program Cancer Research Centre Cytometry Service NUCLEUS Salamanca Spain

Zobrazit více v PubMed

Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Revised 4th ed. Lyon: International Agency for Research on Cancer; 2017. p. 10–13.

Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Revised 4th ed. Lyon: International Agency for Research on Cancer; 2017. p. 199–213.

Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Revised 4th ed. Lyon: International Agency for Research on Cancer; 2017. p. 129–71.

Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Revised 4th ed. Lyon: International Agency for Research on Cancer; 2017. p. 179–87.

Mejstrikova E, Volejnikova J, Fronkova E, Zdrahalova K, Kalina T, Sterba J, et al. Prognosis of children with mixed phenotype acute leukemia treated on the basis of consistent immunophenotypic criteria. Haematologica. 2010;95:928–35. doi: 10.3324/haematol.2009.014506. PubMed DOI PMC

van den Ancker W, Terwijn M, Westers TM, Merle PA, van Beckhoven E, Dräger AM, et al. Acute leukemias of ambiguous lineage: diagnostic consequences of the WHO2008 classification. Leukemia. 2010;24:1392–6. doi: 10.1038/leu.2010.119. PubMed DOI

Flores-Montero J, Sanoja-Flores L, Paiva B, Puig N, García-Sánchez O, Böttcher S, et al. Next generation flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma. Leukemia. 2017;31:2094–103. doi: 10.1038/leu.2017.29. PubMed DOI PMC

Theunissen P, Mejstrikova E, Sedek L, van der Sluijs-Gelling AJ, Gaipa G, Bartels M, et al. Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia. Blood. 2017;129:347–57. doi: 10.1182/blood-2016-07-726307. PubMed DOI PMC

van der Burg M, Kalina T, Perez-Andres M, Vlkova M, Lopez-Granados E, Blanco E, et al. The EuroFlow PID Orientation Tube for flow cytometric diagnostic screening of primary immunodeficiencies of the lymphoid system. Front Immunol. 2019;10. 10.3389/fimmu.2019.00246. PubMed PMC

van Dongen JJM, Lhermitte L, Böttcher S, Almeida J, van der Velden VHJ, Flores-Montero J, et al. EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes. Leukemia. 2012;26:1908–75. doi: 10.1038/leu.2012.120. PubMed DOI PMC

Botafogo V, Pérez-Andres M, Jara-Acevedo M, Bárcena P, Grigore G, Hernández-Delgado A, et al. Age distribution of multiple functionally relevant subsets of CD4+ T cells in human blood using a standardized and validated 14-color EuroFlow immune monitoring tube. Front Immunol. 2020;11:166. PubMed PMC

Kalina T, Flores-Montero J, van der Velden VHJ, Martin-Ayuso M, Böttcher S, Ritgen M, et al. EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols. Leukemia. 2012;26:1986–2010. doi: 10.1038/leu.2012.122. PubMed DOI PMC

Lhermitte L, Mejstrikova E, van der Sluijs-Gelling AJ, Grigore GE, Sedek L, Bras AE, et al. Automated database-guided expert-supervised orientation for immunophenotypic diagnosis and classification of acute leukemia. Leukemia. 2018;32:874–81. doi: 10.1038/leu.2017.313. PubMed DOI PMC

Pedreira CE, Costa ES, Lecrevisse Q, van Dongen JJM, Orfao A, EuroFlow Consortium. Overview of clinical flow cytometry data analysis: recent advances and future challenges. Trends Biotechnol. 2013;31:415–25. doi: 10.1016/j.tibtech.2013.04.008. PubMed DOI

Pedreira CE, Costa ES, Arroyo ME, Almeida J, Orfao A. A multidimensional classification approach for the automated analysis of flow cytometry data. IEEE Trans Biomed Eng. 2008;55:1155–62. doi: 10.1109/TBME.2008.915729. PubMed DOI

Heel K, Tabone T, Röhrig KJ, Maslen PG, Meehan K, Grimwade LF, et al. Developments in the immunophenotypic analysis of haematological malignancies. Blood Rev. 2013;27:193–207. doi: 10.1016/j.blre.2013.06.005. PubMed DOI

Saeys Y, Van Gassen S, Lambrecht BN. Computational flow cytometry: helping to make sense of high-dimensional immunology data. Nat Rev Immunol. 2016;16:449–62. doi: 10.1038/nri.2016.56. PubMed DOI

Lugli E, Roederer M, Cossarizza A. Data analysis in flow cytometry: the future just started. Cytom A. 2010;77:705–13. doi: 10.1002/cyto.a.20901. PubMed DOI PMC

Meehan S, Walther G, Moore W, Orlova D, Meehan C, Parks D, et al. AutoGate: automating analysis of flow cytometry data. Immunol Res. 2014;58:218–23. doi: 10.1007/s12026-014-8519-y. PubMed DOI PMC

Pedreira CE, da Costa ES, Lecrevise Q, Grigore G, Fluxa R, Verde J, et al. From big flow cytometry datasets to smart diagnostic strategies: the EuroFlow approach. J Immunol Methods. 2019;475:112631. PubMed

Flores-Montero J, Grigore G, Fluxá R, Hernández J, Fernandez P, Almeida J, et al. EuroFlow Lymphoid Screening Tube (LST) data base for automated identification of blood lymphocyte subsets. J Immunol Methods. 2019;475:112662. PubMed

van Dongen JJM, van der Burg M, Kalina T, Perez-Andres M, Mejstrikova E, Vlkova M, et al. EuroFlow-based flowcytometric diagnostic screening and classification of primary immunodeficiencies of the lymphoid system. Front Immunol. 2019;10:1271. doi: 10.3389/fimmu.2019.01271. PubMed DOI PMC

Preijers FWMB, Huys E, Favre C, Moshaver B. Establishment of harmonization in immunophenotyping: a comparative study of a standardized one-tube lymphocyte-screening panel. Cytom B Clin Cytom. 2014;86:418–25. doi: 10.1002/cytob.21158. PubMed DOI

Kalina T, Flores-Montero J, Lecrevisse Q, Pedreira CE, van der Velden VHJ, Novakova M, et al. Quality assessment program for EuroFlow protocols: summary results of four-year (2010-3) quality assurance rounds. Cytom A. 2015;87:145–56. doi: 10.1002/cyto.a.22581. PubMed DOI

Kalina T, Brdickova N, Glier H, Fernandez P, Bitter M, Flores-Montero J, et al. Frequent issues and lessons learned from EuroFlow QA. J Immunol Methods. 2018. 10.1016/j.jim.2018.09.008. PubMed

Solly F, Angelot-Delettre F, Ticchioni M, Geneviève F, Rambaud H, Baseggio L, et al. Standardization of flow cytometric immunophenotyping for hematological malignancies: the FranceFlow Group Experience. Cytometry A. 2019. 10.1002/cyto.a.23844. PubMed

Glier H, Heijnen I, Hauwel M, Dirks J, Quarroz S, Lehmann T, et al. Standardization of 8-color flow cytometry across different flow cytometer instruments: a feasibility study in clinical laboratories in Switzerland. J Immunol Methods. 2017. 10.1016/j.jim.2017.07.013. PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...